If you have been reading about pentadecapeptide and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-03-01. Numbers and descriptions here follow the published literature rather than marketing material.
BPC-157 is a synthetic pentadecapeptide, meaning it consists of fifteen amino acids joined in a single chain. Its sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, a fragment corresponding to part of a larger protein found in human gastric juice. The peptide was first described in the 1990s by researchers in Zagreb who were studying gastric protective factors. It is not a naturally circulating hormone; it is a laboratory-made fragment derived from a stomach protein. The name is an abbreviation of body protection compound, with the number referring to the fragment's position in the source protein.
Most published work on BPC-157 comes from animal experiments rather than controlled human trials. Rodent models have examined its effects on gastrointestinal lesions, tendon and ligament injury, and blood vessel formation. These studies are often small and originate from a limited number of research groups, which affects how broadly the findings can be generalized. No large randomized human trial has been reported in the peer-reviewed literature. Discussion of the compound therefore rests largely on preclinical data, and questions about its effects in people remain open rather than settled.
Several mechanisms have been proposed to explain the activity observed in animal models. The most frequently cited involve signaling through vascular endothelial growth factor receptor 2 and modulation of the nitric oxide system. Researchers have also described interactions with protective pathways in the gut lining. These proposed mechanisms appear in the literature as hypotheses supported by preclinical observations, not as confirmed pathways in humans. The precise way the peptide produces its reported effects, and whether those effects carry across species, remain areas of active and unresolved investigation.
Early work on this family of molecules examined fractions of human gastric juice, where a larger protein was reported to protect gastrointestinal tissue in animal models. BPC 157 was designed as a shorter, more stable fragment of that protein and then studied on its own. The peptide itself is not a normal dietary component and is not present in the human body in meaningful quantities. Descriptions of its origin therefore refer to the research lineage of a laboratory molecule rather than to an endogenous or nutritional substance.
The sequence contains an unusually high proportion of proline and glycine, which limits regular secondary structure and contributes to solubility in aqueous media. The compound dissolves readily in water and in normal saline. Because it is a peptide, digestive enzymes are expected to break it down if it is swallowed, a consideration that influences the routes of administration used in animal experiments. Detailed conformational data remain limited, and published structural models are largely computational.
BPC 157 is a synthetic peptide built from fifteen amino acids. The letters stand for body protection compound, and the number is a laboratory code rather than a description of any biological feature. Its single-letter sequence is GEPPPGKPADDAGLV, which corresponds to a calculated mass near 1419.5 daltons. The material is produced by solid-phase peptide synthesis and is distributed as a lyophilized powder, not as a purified extract from a natural source.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic pentadecapeptide | Composed of fifteen amino acid residues |
| Amino acid sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val | Single-letter form GEPPPGKPADDAGLV |
| Original source | Fragment of a protein in human gastric juice | First characterized in the 1990s |
| Number in name | 157 | Refers to the fragment's position in the source protein |
| Human trial evidence | Limited | Preclinical rodent data predominate |
Direct human evidence is scarce. One trial in ulcerative colitis delivered the compound by enema and produced limited publicly reported results without a clear benefit. The compound is not an approved medicine in most jurisdictions. In many markets it is sold as a research chemical; in others it falls under prescription or controlled categories. Regulators have not confirmed any claimed medical use, and product labels rarely undergo premarket review.
Most published reports describe experiments in rodents rather than in people. These studies examine outcomes in tendons, ligaments, bone, stomach lining, and intestinal tissue. In rat and mouse models, a frequently reported effect is faster healing or reduced damage. Sample sizes are usually small, and a substantial share of the work originates from a small number of research groups. Independent replication is limited, so how far the findings extend to humans remains an open question.
Proposed mechanisms in the literature involve the nitric oxide system, vascular endothelial growth factor signaling, and epidermal growth factor receptor pathways. Some studies report changes in blood vessel formation or in inflammatory mediators, while others describe interactions with nervous tissue. Much of this evidence rests on molecular markers in cultured cells or animal models. Whether the same pathways operate the same way in humans has not been established. Authors therefore tend to describe mechanisms as hypothetical rather than settled.
Quality assessment rests on two separate questions: whether the chain is the intended one, and how much of the sample is that chain. Reverse-phase high-performance liquid chromatography with ultraviolet detection is the standard purity measurement, while mass spectrometry confirms identity through the observed molecular mass. Amino acid analysis and sequence verification provide further checks. A reported purity percentage describes the proportion of the sample represented by the main peak, not the amount of peptide by mass, since counter-ions and water make up part of any lyophilized lot.
In its usual supplied form, the peptide is a white to off-white lyophilized powder that dissolves readily in water and in aqueous buffers. Powder keeps far longer than solution, so material is normally shipped and stored dry, then dissolved only when needed. Once in solution, the chain is subject to hydrolysis and the liquid supports microbial growth, and practical guidance generally treats the dissolved form as short-lived. Containers should stay sealed and desiccated, because the powder takes up moisture from air.
Fluorescent labels can be hybridized to mRNA to help visualize interaction and activity, such as mRNA localization. An antisense strand labeled with the fluorescent probe is attached to a single mRNA strand, and can then be viewed during cell development to see the movement of mRNA within the cell.
The Soviet Zond spacecraft was not yet ready for piloted circumlunar missions in 1968, after six unsuccessful automated test launches: Kosmos 146 on March 10, 1967; Kosmos 154 on April 8, 1967; Zond 1967A on September 28, 1967; Zond 1967B on November 22, 1967; Zond 1968A on April 23, 1968; and Zond 1968B in July 1968. Zond 4 was launched on March 2, 1968, and successfully made a circumlunar flight, but encountered problems with its Earth reentry on March 9, and was ordered destroyed by an explosive charge 15,000 meters (49,000 ft) over the Gulf of Guinea. The Soviet official announcement said that Zond 4 was an automated test flight which ended with its intentional destruction, due to its recovery trajectory positioning it over the Atlantic Ocean instead of over the USSR. During the summer of 1968, the Apollo program hit another snag: the first pilot-rated Lunar Module (LM) was not ready for orbital tests in time for a December 1968 launch. NASA planners overcame this challenge by changing the mission flight order, delaying the first LM flight until March 1969, and sending Apollo 8 into lunar orbit without the LM in December. This mission was in part motivated by intelligence rumors the Soviet Union might be ready for a piloted Zond flight in late 1968. In September 1968, Zond 5 made a circumlunar flight with tortoises on board and returned safely to Earth, accomplishing the first successful water landing of the Soviet space program in the Indian Ocean.
Unsepttrium, element 173, may be an even better heavier homologue of ununennium; with a predicted electron configuration of [Usb] 6g1, it returns to the alkali-metal-like situation of having one easily removed electron far above a closed p-shell in energy, and is expected to be even more reactive than caesium.
== Regulations == Most countries (except Switzerland) at present do not possess a legal definition of absinthe (unlike Scotch whisky or cognac). Accordingly, producers are free to label a product "absinthe" or "absinth", whether or not it bears any resemblance to the traditional spirit.
Sources: en.wikipedia.org
In 2019, the non-profit labor justice organization Fair World Project released an article outling how despite Starbucks had passed coffee producers as slave free in their Brazil production units using their internal C.A.F.E. certification standards, that Brazilian labor inspectors had proof of child slave labor practices being present in their supply chain. In 2022 Starbucks announced that they were going to stop certifying their coffee beans as fairtrade, in favor of their own in-house investigations.
== Copper Canyon Ultra Marathon == In 2003, True decided to organize a race for the Tarahumara natives that would help them preserve their culture and running heritage. The first Copper Canyon Ultra Marathon was held on March 23, 2003; though turnout was small, it became an annual tradition. In 2006, True had the idea of inviting American ultrarunners to compete with the Tarahumara. After initially reaching out on the internet, he wrote an article in Men's Health, elucidating many of the lessons he internalized from the Tarahumara people. He also contacted Christopher McDougall, a writer for Men's Health, who would later write the book Born to Run. The 2012 event took place on March 12 and was the largest ever with hundreds of participants. Most were local Tarahumara, known for their running endurance, both as a general means of travel and while participating in ceremonial, team-based, long distance running events, most famously the Rarajipari, or ball game. In addition to prize money for the top ten finishers, the event awards seed corn vouchers to all runners who complete the distance. The race has its start and finish in the town square of Urique, Chihuahua, Mexico, covering an estimated 50 miles (80 km) of single track trail and dirt road.
The discontinued offerings were primarily less popular or more complex items, including some Frappuccino blended drinks, Royal English Breakfast Latte, and White Hot Chocolate. In July 2025, Starbucks announced corporate office employees would have to return to working physically in the office four days per week, starting in October. For workers who would prefer to instead leave the company, Starbucks would offer a one-time voluntary exit program which would include a cash payment. In January 2026, Starbucks announced their turnaround strategy which involved forming a joint venture with Boyu Capital to run its business in China, the company’s second-largest market. After the deal closes in the second quarter of fiscal 2026, pending regulatory approval, Boyu will hold up to a 60% interest in the joint venture. In March 2026, Starbucks announced plans for new regional corporate offices, making a massive expansion by establishing a major corporate hub in Nashville, Tennessee. The company is investing $100 million into this new regional headquarters, which will house up to 2,000 employees over the next five years.
== Early life == Farthing was born on 22 April 1953 in Christchurch, New Zealand. His father was an accountant and his mother was a music teacher. He was educated at Christ's College, Christchurch, an independent boys school. As a child he had considered entering the priesthood. He went on to study medicine at the University of Otago in Dunedin.
=== Progesterone === Progesterone is a naturally occurring steroid hormone and is used in hormone therapy and birth control pills, among other applications. There are two known forms of naturally occurring progesterone (or nat‐progesterone), and other synthetic polymorphs of the hormone have also been created and studied. Early scientists reported being able to crystallize both Form 1 and Form 2 of nat‐progesterone, and they could convert Form 2 into Form 1, which has higher melting point (129–131 °C instead of 121–123 °C), and is more thermodynamically stable by heat capacity experiments. When later scientists tried to crystallize Form 2 from pure materials, they could not. Attempts to replicate older instructions (and variations on those instructions) for crystallization of Form 2 invariably produced Form 1 instead, sometimes even leading to crystals of exceptional purity but still of Form 1. Researchers have tentatively suggested that Form 2 became harder to produce already by 1975, based on a review of production difficulties documented or alluded to in existing literature. Form 2 was eventually successfully synthesized by using pregnenolone, a structurally similar compound, as an additive in the crystallization process. The additive seemed to reverse the order of stability of the polymorphs.
Sources: en.wikipedia.org
It is a chain of fifteen amino acids, referred to as a pentadecapeptide. The sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It corresponds to a fragment of a protein found in human gastric juice.
It is neither a naturally circulating hormone nor an approved medicine in most countries. It is a synthetic peptide fragment used chiefly as a laboratory research material. Its regulatory status varies by jurisdiction, and it is not authorized as a therapeutic product in the United States or the European Union.
Published human evidence is very limited. Most findings come from rodent studies conducted by a small number of groups. As a result, statements about its effects in humans are generally described as uncertain rather than established.
It is a synthetic peptide. Its design was inspired by a fragment of a protein found in human gastric juice, but the fifteen-amino-acid molecule itself is made in a laboratory and is not a normal component of food or of human tissue in appreciable amounts.